Role of melanoma-promoting protein revealed

December 6, 2017 by Ziba Kashef, Yale University
Credit: stock.adobe.com

In a new study, Yale researchers describe the role of a protein that promotes growth of melanoma, the deadliest form of skin cancer.

The gene, MELK, encodes a kinase—an enzyme that modifies other proteins—and is over-expressed in melanoma patient samples compared to normal skin. The research team, led by associate professor of pathology Narendra Wajapayee, analyzed human melanoma cells to determine how MELK stimulates cancer growth, and whether they could block its activity to prevent melanoma growth and enhance the efficacy of existing therapies that target the BRAF cancer gene.

The researchers found that MELK is regulated by key melanoma-promoting cancer genes, including BRAF. Additionally, they revealed that MELK regulates the modification of several cellular proteins that were previously described as either BRAF or MEK targets. Additional experiments using drugs or through genetic techniques revealed that MELK targeting might be a promising therapeutic option for treating .

The study is published in Cell Reports.

Explore further: Scientists identify novel therapeutic targets for metastatic melanoma

More information: Radoslav Janostiak et al. MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway, Cell Reports (2017). DOI: 10.1016/j.celrep.2017.11.033

Related Stories

Scientists identify novel therapeutic targets for metastatic melanoma

November 27, 2017
Mount Sinai researchers have identified novel therapeutic targets for metastatic melanoma, according to a study published in Molecular Cell.

Protein critical to early stages of cellular HIV infection identified

August 8, 2017
When a virus enters a cell, one of the first steps in the process of infecting that cell is removal of the protein coat that surrounds the virus's genetic material. The virus can then produce DNA from its own genes and insert ...

Melanoma cells rewire to resist drug treatment

September 27, 2017
In 2014, new combination therapies to treat patients with metastatic melanoma hit the market, helping extend the lives of those with this aggressive disease. Yet unfortunately, after several months of treatment, almost all ...

A tiny RNA with a big role in melanoma

February 18, 2014
A Yale-led study has identified a key mechanism in the regulation of gene expression that promotes the proliferation of melanoma cells. The finding opens a possible avenue for development of treatments that target this mechanism. ...

Researchers identify super-oncogenic protein that promotes development of melanoma

May 19, 2016
An international collaborative study led by scientists at the Sanford Burnham Prebys Medical Discovery Institute (SBP) has identified a malicious form of a protein that drives the formation of melanoma. The findings, published ...

New insight into drug resistance in metastatic melanoma

June 3, 2014
(Medical Xpress)—A study by scientists in Manchester has shown how melanoma drugs can cause the cancer to progress once a patient has stopped responding to treatment.

Recommended for you

Healthy diets linked to better outcomes in colorectal cancer

October 20, 2018
Colorectal cancer patients who followed healthy diets had a lower risk of death from colorectal cancer and all causes, even those who improved their diets after being diagnosed, according to a new American Cancer Society ...

Why some cancers affect only young women

October 19, 2018
Among several forms of pancreatic cancer, one of them specifically affects women, often young. How is this possible, even though the pancreas is an organ with little exposure to sex hormones? This pancreatic cancer, known ...

Scientists to improve cancer treatment effectiveness

October 19, 2018
Together with researchers from the University of Nantes and the University of Reims Champagne-Ardenne in France, experts from the National Research Nuclear University MEPhI have recently developed a quantum dot-based microarray ...

Mutant cells colonize our tissues over our lifetime

October 18, 2018
By the time we reach middle age, more than half of the oesophagus in healthy people has been taken over by cells carrying mutations in cancer genes, scientists have uncovered. By studying normal oesophagus tissue, scientists ...

Study involving hundreds of patient samples may reveal new treatment options of leukemia

October 17, 2018
After more than five years and 672 patient samples, an OHSU research team has published the largest cancer dataset of its kind for a form of leukemia. The study, "Functional Genomic Landscape of Acute Myeloid Leukemia", published ...

A 150-year-old drug might improve radiation therapy for cancer

October 17, 2018
A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study led by researchers at The Ohio State University Comprehensive Cancer ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.